Multi‐omics profiling of primary hepatic stellate cells from advanced liver fibrosis patients reveals distinctive molecular signatures

BACKGROUND AND AIM Hepatic fibrosis is a common pathogenic outcome of almost all chronic liver diseases and a growing public health problem globally. However, the key genes or proteins driving liver fibrosis and cirrhosis are not well understood. We aimed to identify novel hepatic fibrosis genes of human primary hepatic stellate cells (HSCs). METHODS Human primary HSCs were isolated from surgically resected advanced fibrosis liver tissues (n = 6) and surgical resection of normal liver tissue around hemangioma (n = 5). Differences in the expression levels of mRNA and proteins from HSCs in advanced fibrosis group and the control group were analyzed using RNA sequencing and mass spectrometry as transcriptomic and proteomic approaches. The obtained biomarkers were further validated through real-time quantitative polymerase chain reaction (RT-qPCR), immunofluorescence, and Western blot. RESULTS A total of 2156 transcripts and 711 proteins were found to be differently expressed between the advanced fibrosis group and the control group patients. The Venn diagram shows that a total of 96 upregulated molecules are overlapped in both the transcriptomic and proteomic datasets. Gene Ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes analysis indicated that those overlapped genes were mainly involved in wound healing, cell adhesion regulation, and actin binding, which reflects the major biological conversions in liver cirrhosis process. Pyruvate kinase M2 and EH domain-containing 2 were identified as potential new markers for advanced liver cirrhosis, which have been validated in primary human HSCs and in vitro cellular hepatic fibrosis model Lieming Xu-2 (LX-2) cells. CONCLUSIONS Our results revealed the major transcriptomic and proteomic changes during liver cirrhosis process and identified new biomarkers and potential therapeutic targets for advanced liver fibrosis.

[1]  N. Takizawa,et al.  The well-developed actin cytoskeleton and Cthrc1 expression by actin-binding protein drebrin in myofibroblasts promote cardiac and hepatic fibrosis , 2023, The Journal of biological chemistry.

[2]  Zhengyu He,et al.  Integrin β3-PKM2 pathway-mediated aerobic glycolysis contributes to mechanical ventilation-induced pulmonary fibrosis , 2022, Theranostics.

[3]  I. Ng,et al.  Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer , 2022, Nature communications.

[4]  Hongbing Shen,et al.  FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2 , 2022, Gut.

[5]  P. Lo,et al.  Bioorthogonal Conjugation-Assisted Purification Method for Profiling Cell Surface Proteome. , 2022, Analytical chemistry.

[6]  J Zhang,et al.  MyD88 in myofibroblasts regulates aerobic glycolysis‐driven hepatocarcinogenesis via ERK‐dependent PKM2 nuclear relocalization and activation , 2021, The Journal of pathology.

[7]  Zhenqiang Gao,et al.  PKM2 promotes angiotensin‐II‐induced cardiac remodelling by activating TGF‐β/Smad2/3 and Jak2/Stat3 pathways through oxidative stress , 2021, Journal of cellular and molecular medicine.

[8]  Jenny J. Yang,et al.  Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts , 2021, Theranostics.

[9]  D. Koya,et al.  The PKM2 activator TEPP‐46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF‐1α accumulation , 2020, Journal of diabetes investigation.

[10]  E. Crouchet,et al.  Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives , 2020, Cells.

[11]  E. Cartwright,et al.  Cardiomyocyte damage control in heart failure and the role of the sarcolemma , 2019, Journal of Muscle Research and Cell Motility.

[12]  Alireza Hadj Khodabakhshi,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[13]  M. Pinzani,et al.  Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. , 2019, Molecular aspects of medicine.

[14]  Christopher P. Long,et al.  Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin , 2018, Nature Communications.

[15]  Hyojin Kim,et al.  TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions , 2017, Nucleic Acids Res..

[16]  Lei Ye,et al.  Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model , 2017, BMC Genomics.

[17]  S. Lydersen,et al.  Risk factors of admission for acute colonic diverticulitis in a population-based cohort study: The North Trondelag Health Study, Norway , 2016, World journal of gastroenterology.

[18]  S. Narumiya,et al.  Roles of hepatic stellate cells in liver inflammation: a new perspective , 2016, Inflammation and regeneration.

[19]  Salvatore Papa,et al.  PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation , 2015, Nature Communications.

[20]  G. Elpek.  Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. , 2014, World journal of gastroenterology.

[21]  T. Mielke,et al.  Structural insights into membrane interaction and caveolar targeting of dynamin-like EHD2. , 2014, Structure.

[22]  N. Naslavsky,et al.  Scratching the surface: actin' and other roles for the C-terminal Eps15 homology domain protein, EHD2. , 2014, Histology and histopathology.

[23]  Jia-Horng Kao,et al.  Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update , 2012, Hepatology International.

[24]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[25]  H. Denk,et al.  Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. , 1991, The American journal of pathology.

[26]  J. Ladero,et al.  Liver fibrosis. , 2018, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[27]  D. Brenner,et al.  Human hepatic stellate cell isolation and characterization , 2017, Journal of Gastroenterology.

[28]  B. Tian,et al.  RNA‐Seq methods for transcriptome analysis , 2017, Wiley interdisciplinary reviews. RNA.

[29]  A. Jemal,et al.  Global Cancer Statistics , 2011 .